Introduction of zwitterionic motifs into bacterial polysaccharides generates TLR2 agonists able to activate APCs

Journal of Immunology

Volumn 179, Issue 12, 2007, Pages 8208-8215

  Gallorini, Simona ^a   Berti, Francesco ^a   Parente, Pierino ^a   Baronio, Roberta ^a,b   Aprea, Susanna ^a   D'Oro, Ugo ^a   Pizza, Mariagrazia ^a   Telford, John L ^a   Wack, Andreas ^a  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOLYTE; ANION; BACTERIAL POLYSACCHARIDE; BIOLOGICAL MARKER; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR AGONIST;

ANIMAL CELL; ARTICLE; BONE MARROW; CELL ACTIVATION; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; STREPTOCOCCUS AGALACTIAE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION; ANTIGEN PRESENTING CELL; CELL LINE; CHEMISTRY; DRUG EFFECT; DRUG POTENTIATION; IMMUNOLOGY;

ANTIGEN-PRESENTING CELLS; CELL LINE; HUMANS; POLYSACCHARIDES, BACTERIAL; TOLL-LIKE RECEPTOR 2;

EID: 40049102556     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.12.8208     Document Type: Article

References (28)

1. Tzianabos, A. O., J. Y. Wang, and J. C. Lee. 2001. Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides. Proc. Natl. Acad. Sci. USA 98: 9365-9370.
2. Brubaker, J. O., Q. Li, A. O. Tzianabos, D. L. Kasper, and R. W. Finberg. 1999. Mitogenic activity of purified capsular polysaccharide A from Bacteroides fragilis: differential stimulatory effect on mouse and rat lymphocytes in vitro. J. Immunol. 162: 2235-2242.
3. Kalka-Moll, W. M., A. O. Tzianabos, P. W. Bryant, M. Niemeyer, H. L. Ploegh, and D. L. Kasper. 2002. Zwitterionic polysaccharides stimulate T cells by MHC class II-dependent interactions. J. Immunol. 169: 6149-6153.
4. Stephen, T. L., M. Niemeyer, A. O. Tzianabos, M. Kroenke, D. L. Kasper, and W. M. Kalka-Moll. 2005. Effect of B7-2 and CD40 signals from activated antigen-presenting cells on the ability of zwitterionic polysaccharides to induce T-cell stimulation. Infect. Immun. 73: 2184-2189.
5. Stingele, F., B. Corthesy, N. Kusy, S. A. Porcelli, D. L. Kasper, and A. O. Tzianabos. 2004. Zwitterionic polysaccharides stimulate T cells with no preferential Vβ usage and promote anergy, resulting in protection against experimental abscess formation. J. Immunol. 172: 1483-1490.
6. Tzianabos, A. O., R. W. Finberg, Y. Wang, M. Chan, A. B. Onderdonk, H. J. Jennings, and D. L. Kasper. 2000. T cells activated by zwitterionic molecules prevent abscesses induced by pathogenic bacteria. J. Biol. Chem. 275: 6733-6740.
7. Kalka-Moll, W. M., A. O. Tzianabos, Y. Wang, V. J. Carey, R. W. Finberg, A. B. Onderdonk, and D. L. Kasper. 2000. Effect of molecular size on the ability of zwitterionic polysaccharides to stimulate cellular immunity. J. Immunol. 164: 719-724.
8. Tzianabos, A. O., A. B. Onderdonk, B. Rosner, R. L. Cisneros, and D. L. Kasper. 1993. Structural features of polysaccharides that induce intra-abdominal abscesses. Science 262: 416-419.
9. Tzianabos, A. O., and D. L. Kasper. 2002. Role of T cells in abscess formation. Curr. Opin. Microbiol. 5: 92-96.
10. + T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J. Immunol. 170: 1958-1963.
11. Cobb, B. A., Q. Wang, A. O. Tzianabos, and D. L. Kasper. 2004. Polysaccharide processing and presentation by the MHCII pathway. Cell 117: 677-687.
12. Wang, Q., R. M. McLoughlin, B. A. Cobb, M. Charrel-Dennis, K. J. Zaleski, D. Golenbock, A. O. Tzianabos, and D. L. Kasper. 2006. A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2. J. Exp. Med. 203: 2853-2863.
13. Maione, D., I. Margarit, C. D. Rinaudo, V. Masignani, M. Mora, M. Scarselli, H. Tettelin, C. Brettoni, E. T. Iacobini, R. Rosini, et al. 2005. Identification of a universal group B streptococcus vaccine by multiple genome screen. Science 309: 148-150.
14. Wessels, M. R., L. C. Paoletti, D. L. Kasper, J. L. DiFabio, F. Michon, K. Holme, and H. J. Jennings. 1990. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B streptococcus. J. Clin. Invest. 86: 1428-1433.
15. Paoletti, L. C., D. L. Kasper, F. Michon, J. DiFabio, H. J. Jennings, T. D. Tosteson, and M. R. Wessels. 1992. Effects of chain length on the immunogenicity in rabbits of group B streptococcus type III oligosaccharide- tetanus toxoid conjugates. J. Clin. Invest. 89: 203-209.
16. Costantino, P., S. Viti, A. Podda, M. A. Velmonte, L. Nencioni, and R. Rappuoli. 1992. Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C. Vaccine 10: 691-698.
17. Sen, G., A. Q. Khan, Q. Chen, and C. M. Snapper. 2005. In vivo humoral immune responses to isolated pneumococcal polysaccharides are dependent on the presence of associated TLR ligands. J. Immunol. 175: 3084-3091.
18. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rossner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77-92.
19. Shimizu, T., Y. Kida, and K. Kuwano. 2005. A dipalmitoylated lipoprotein from Mycoplasma pneumoniae activates NF-κB through TLR1, TLR2 and TLR6. J. Immunol. 175: 4641-4646.
20. Zanoni, I., M. Foti, P. Ricciardi-Castagnoli, and F. Granucci. 2005. TLR-dependent activation stimuli associated with Th1 responses confer NK cell stimulatory capacity to mouse dendritic cells. J. Immunol. 175: 286-292.
21. Jackson, D. C., Y. F. Lau, T. Le, A. Suhrbier, G. Deliyannis, C. Cheers, C. Smith, W. Zeng, and L. E. Brown. 2004. A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses. Proc. Natl. Acad. Sci. USA 101: 15440-15445.
22. Querec, T., S. Bennouna, S. Alkan, Y. Laouar, K. Gorden, R. Flavell, S. Akira, R. Ahmed, and B. Pulendran. 2006. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J. Exp. Med. 203: 413-424.
23. Komai-Koma, M., L. Jones, G. S. Ogg, D. Xu, and F. Y. Liew. 2004. TLR2 is expressed on activated T cells as a costimulatory receptor. Proc. Natl. Acad. Sci. USA 101: 3029-3034.
24. + regulatory T cells. Proc. Natl. Acad. Sci. USA 103: 7048-7053.
25. Cottalorda, A., C. Verschelde, A. Marcais, M. Tomkowiak, P. Musette, S. Uematsu, S. Akira, J. Marvel, and N. Bonnefoy-Berard. 2006. TLR2 engagement on CD8 T cells lowers the threshold for optimal antigen-induced T cell activation. Eur. J. Immunol. 36: 1684-1693.
26. Wang, J. E., P. F. Jorgensen, M. Almlof, C. Thiemermann, S. J. Foster, A. O. Aasen, and R. Solberg. 2000. Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor α, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model. Infect. Immun. 68: 3965-3970.
27. Mattern, T., H. D. Flad, L. Brade, E. T. Rietschel, and A. J. Ulmer. 1998. Stimulation of human T lymphocytes by LPS is MHC unrestricted, but strongly dependent on B7 interactions. J. Immunol. 160: 3412-3418.
28. + hematopoietic stem cells exert accessory function in lipopolysaccharide-induced T cell stimulation and CD80 expression on monocytes. J. Exp. Med. 189: 693-700.